Principaux concurrents
PER (N) Price to Book (N) PEG (N) VE / CA (N) VE / EBITDA (N) VE / EBIT (N) Rendement du dividende (N) Capi.($)
-2.92x - -0.36x - - - - 14,84 M
20.76x4.01x-2.43x6.35x13.89x16.01x1,53 % 55,23 Md
31.7x6.02x0.82x7.83x24.1x24.59x0,05 % 53,75 Md
-18.35x1.13x2.83x4.4x-7.71x-6.5x-.--% 23,48 Md
-39.73x51.3x0.66x12.6x-37.13x-40.74x-.--% 22 Md
24.86x2.43x1.91x4.85x12.85x15.36x-.--% 19,78 Md
24.09x2.73x-1.14x4.69x15.26x17.2x-.--% 17,44 Md
-736.67x18.15x11.26x34.86x-3924.15x-493.12x-.--% 14,66 Md
17.61x5.01x1.23x5.1x11.9x12.95x-.--% 14,07 Md
39.36x10.09x0.35x15.8x40.68x37.32x0,09 % 13,02 Md
-73.12x26.14x1.54x7.16x-50.99x-60.14x-.--% 11,37 Md
-27.1x29.03x-0x25.61x-32.34x-26.03x-.--% 12,3 Md
-5035.26x7.76x51.01x13.61x90.8x404.35x-.--% 10,95 Md
-12.58x-87.37x5.57x91.54x-14.27x-13.87x-.--% 10,92 Md
-11.08x39.52x0.72x2476.65x-13.12x-11.41x-.--% 10,72 Md
-17.72x8.81x3.79x113.63x-15.89x-14.44x - 8,82 Md
-33.03x9.08x-0.6x - -30.59x-29.59x-.--% 8,93 Md
11.3x5.55x0.03x7.14x10.95x10.61x-.--% 7,93 Md
18.87x5.34x0.72x - - - 0,4 % 7,69 Md
-6.57x - -0.13x - -6.74x-6.2x-.--% 8,08 Md
Moyenne -291,28x 8,04x 3,89x 176,99x -217,36x -9,09x 0,12 % 16,56 Md
Moyenne pondérée par Capi. -194,44x 8,41x 2,64x 102,07x -172,84x -6,21x 0,28 %
Médicaments bio-thérapeutiques
🔇